A2 Milk Explained: The Science, India’s Indigenous Breeds, and Why It Matters for the World

In markets from Mumbai to Melbourne, from Lagos to London, a quietly growing segment of dairy has been reshaping how consumers think about milk. A2 milk — once considered niche, sometimes dismissed as premium marketing — is now a USD 1.40 billion market in India alone, projected to grow at 12.1% annually to reach USD 4.30 billion by 2033. Globally, Asia Pacific is leading the growth, accounting for the largest market share at 53.7% as of 2024.

But what is A2 milk, really? Is the science behind it robust or overstated? And why does it intersect so profoundly with India’s ancient livestock heritage — and with the livelihoods of millions of smallholder dairy farmers across the Global South?

These are questions worth answering carefully. Not with the enthusiasm of a marketing brochure, and not with the cynicism of someone who has not read the research. At Shunya, we work at the intersection of animal nutrition, dairy systems, and rural livelihoods every day. Our obligation is to tell this story accurately, backed by the best evidence available, with the complexity it deserves.

What Is A2 Milk? Starting with the Protein, Not the Hype

To understand A2 milk, you need to understand a little about milk protein — specifically beta-casein, one of the most abundant proteins in bovine milk. Beta-casein accounts for roughly 30–35% of total milk protein. It is not a single uniform molecule. It comes in multiple genetic variants, of which two are most commercially relevant: A1 beta-casein and A2 beta-casein.

The distinction between these two variants is extraordinarily small at the molecular level. The entire difference — between what becomes “A1 milk” and what becomes “A2 milk” — comes down to a single amino acid substitution at position 67 of the protein chain. In A1 beta-casein, that position carries histidine. In A2 beta-casein, the same position carries proline.

That tiny substitution turns out to matter during digestion. When digestive enzymes act on A1 beta-casein, they can cleave the protein at the histidine-67 position — releasing a small bioactive peptide called BCM-7 (beta-casomorphin-7). When the same enzymes act on A2 beta-casein, the proline at position 67 creates a stronger bond that resists cleavage — significantly reducing or eliminating BCM-7 release.

BCM-7 is an opioid-like peptide. This does not mean it causes addiction or euphoria from drinking milk. It means it shares structural features with opioid peptides and can interact with opioid receptors in the gut and, potentially, the nervous system. The research question — still actively being investigated — is what those interactions mean for human health.

What the Research Actually Says: Digestive Benefits Are Real, Grand Claims Are Not

The scientific literature on A2 milk has grown considerably over the past decade. It is worth examining what the evidence actually says — both where it is strong and where it remains contested.

The Digestive Comfort Evidence: Reasonably Robust

The strongest body of evidence relates to digestive symptoms. A 2024 randomised, double-blind, cross-over study published in PMC (PMC11215337) found that A2 milk caused significantly less abdominal pain, fecal urgency, and borborygmus (audible gut sounds) compared to conventional A1/A2 milk. Notably, fecal calprotectin — a biomarker for intestinal inflammation — decreased or rose less after A2 milk consumption compared to conventional milk.

A 2022 bibliometric and review analysis of worldwide research (PMC10542606) confirmed that human studies across multiple populations suggest consumption of A1 beta-casein may negatively influence gut health by altering microbial composition, reducing intestinal motility, and increasing colonic fermentation. A 2025 Nutrition Reviews narrative review examined preclinical, animal, and human studies on the gut–brain axis effects of different beta-casein variants, further advancing the mechanistic understanding.

Where the Evidence Remains Contested

Several early claims about A2 milk went well beyond the evidence. Associations between A1 milk consumption and type 1 diabetes, autism spectrum disorders, cardiovascular disease, and neurological disorders were proposed in early literature. These claims were subsequently reviewed by major scientific bodies — including the European Food Safety Authority (EFSA) — and found to be insufficiently supported by robust clinical evidence.

A 2023 review in PMC (PMC10486734) assessing BCM-7 adverse effects acknowledged that while preclinical data shows interesting signals, establishing causality from A1 milk consumption to specific diseases in humans remains methodologically difficult. The honest scientific position, as of 2026, is:

India’s Indigenous Breeds: The A2 Advantage Is Not an Accident

This is where the A2 milk story takes on a dimension that goes far beyond protein biochemistry. India’s contribution to the global A2 conversation is not merely geographical — it is genetic, historical, and civilisational.

India’s native cattle belong primarily to the Bos indicus family — the humped zebu cattle that evolved across the Indian subcontinent over thousands of years. These breeds are genetically distinct from the Bos taurus cattle of European origin. And at the beta-casein gene, that distinction is decisive.

Research conducted by NBAGR (National Bureau of Animal Genetic Resources) and published through ISPGR shows that across approximately 22 desi cattle breeds studied, the A2 allele frequency stands at 0.95. The A2A2 genotype frequency across these native breeds is 0.905 — meaning over 90% of India’s indigenous cattle are homozygous A2A2 producers.

By contrast, European origin breeds that dominate global commercial dairy — particularly Holstein Friesian and Ayrshire — carry significantly higher frequencies of the A1 allele. This is not a recent discovery; it reflects the divergent evolutionary and selective breeding histories of the two lineages. European dairy breeding, optimised over centuries for maximum milk volume, inadvertently selected for higher A1 prevalence. Indian native breeds, shaped by different selection pressures and breeding systems, retained their predominantly A2 character.

The High-A2 Native Breeds of India

Sources: NBAGR breed profiles; ISPGR genetic studies; ICAR-NDDB breed documentation; Animal Biotechnology, 2023.

What About Buffalo Milk?

A commonly overlooked fact: India’s enormous buffalo milk production — which constitutes the majority of the country’s dairy output by fat content — also predominantly carries the A2-type beta-casein. Murrah, Surti, Mehsana, and other Indian buffalo breeds are predominantly A2 producers. This means that the traditional Indian dairy diet — heavy in buffalo-origin milk, dahi, lassi, and ghee — has been almost entirely A2-based for millennia. The emergence of A2 as a commercial category is really a rediscovery and codification of what Indian dairy always was.

The Misconceptions That Need to Be Cleared Up

The rapid commercialisation of A2 milk in India has generated both genuine consumer interest and a fair amount of confusion. Several misconceptions circulate regularly and deserve direct correction.

The Commercial A2 Market in India: From Niche to Mainstream

India’s A2 dairy market has moved from a niche premium play to a mainstream consumer segment in the span of less than a decade. The combination of rising urban health awareness, growing gut health consciousness, and deep cultural resonance with indigenous cattle has made A2 positioning one of the most commercially potent in the dairy sector.

Who Is Driving the Market?

Three distinct consumer motivations are converging to create A2 demand in India and across the Global South:

What Is Entering the Indian Market

The scale of commercial activity now building around A2 milk in India is significant. Mother Dairy introduced an A2 buffalo milk product in Delhi-NCR in January 2024, targeting a ₹500 crore brand value by March 2025. Nestlé has launched turmeric-infused A2 milk. Startups including Country Delight, Sid’s Farm, and Akshayakalpa are operating subscription direct-to-consumer models achieving gross margins of 28–32%. The entry of large organised players validates what smaller native-breed dairy farms have known for several years: the A2 segment carries genuine consumer demand, not merely speculation.

The Bigger Picture: Why A2 Milk Is More Than a Nutrition Story

If A2 milk were only about digestive comfort, it would be a useful but narrow story — a dietary solution for a subset of individuals with gut sensitivity. What makes it genuinely significant — particularly from the vantage point of the Global South — is that it intersects with at least five other critical conversations simultaneously.

1. Indigenous Breed Conservation

India’s native cattle breeds are under sustained genetic pressure. The decades-long push for maximum milk yield led to widespread crossbreeding with Holstein Friesian and Jersey — breeds that produce more milk but shed the genetic heritage of indigenous populations. Several native breeds are now classified as endangered or vulnerable by NBAGR. The commercial premium attached to A2 milk — particularly when it is breed-specific and traceable — creates a genuine economic argument for maintaining pure native breed herds. Every Gir cow retained in a pure-breeding programme is a node in an irreplaceable genetic resource network.

2. Rural Dairy Economics

The economics of smallholder dairy farming in India are under pressure from multiple directions: stagnant farm-gate milk prices, rising input costs, seasonal fodder scarcity, and increasing veterinary expenses. A2 milk premium pricing — when it reaches farmers rather than being captured entirely by brands — can meaningfully improve the income per litre produced by native breed farmers. This is a direct rural livelihoods intervention, not just a nutritional story.

3. Ayurveda and Traditional Food Systems

Classical Ayurvedic texts differentiate extensively between the properties of milk from different species and even different breeds of cattle. The traditional preference for milk from indigenous cows — particularly Gir and Sahiwal — described in Charaka Samhita and Sushruta Samhita as having specific therapeutic and nutritive properties — finds an unexpected empirical resonance in modern beta-casein research. The ancestral intuition and the molecular biology are not in conflict. They describe the same underlying reality from different epistemic frameworks.

4. The Global South Dimension

This is perhaps the most underappreciated dimension of the A2 story. The Bos indicus cattle family — the humped zebu — is the foundational livestock population not just of India but of much of sub-Saharan Africa, Southeast Asia, and Latin America. Brazilian Nelore and Guzerat (derived from Indian Kankrej and Gir); East African Zebu; Southeast Asian Bali cattle — all carry predominantly A2 beta-casein genetics. The A2 milk opportunity is not uniquely Indian. It is a Global South opportunity, rooted in the bovine heritage of tropical agriculture.

5. Animal Genetics and Precision Breeding

The growing availability of affordable PCR-based genetic testing has made it possible to systematically verify A2A2 genotype at the individual animal level. NBAGR offers genotyping services at nominal cost. As genomic selection tools become more widely available in developing country contexts, the ability to breed selectively for A2A2 status within indigenous breed populations — without sacrificing other adaptive traits — will become a realistic programme objective for national breed improvement schemes. The genetics and the economics are aligning.

What A2 Milk Means at the Farm Level: The Shunya Perspective

At Shunya, we work with dairy farmers across India through our Fodder-as-a-Service model — delivering fresh, high-quality hydroponic green fodder to rural doorsteps to address the chronic green nutrition gap that suppresses milk yield and livestock health in smallholder systems. The A2 milk narrative intersects directly with our work in several important ways.

First, indigenous breed farmers — the ones raising Gir, Sahiwal, and Tharparkar cattle for A2 premium markets — are often operating under the same structural fodder deficit as any other smallholder dairy farmer. Premium market positioning on the output side does not automatically solve the input-side nutrition challenge. A Gir cow producing A2 milk but receiving inadequate green fodder is producing below her genetic potential — and the A2 premium is being left partially on the table.

Consistent, high-quality green fodder — delivered reliably, year-round, independent of seasonal availability — is the input that unlocks the full productive potential of native breed A2 dairy cows. The combination of breed genetics (A2A2) and nutrition (consistent green fodder) is what allows farmers to fully realise the economic value of their indigenous cattle. Neither alone is sufficient.

Second, the traceability story that A2 premium markets require — verification of breed, genotype, feeding practices, and production conditions — is exactly the kind of digital infrastructure that Shunya’s Production OS and Intelligence Layer are designed to support. Premium dairy markets are built on trust and verification. The infrastructure for that trust does not exist by default. It must be built.

Where Does A2 Milk Fit in the Global Dairy Transition?

Globally, the dairy sector is undergoing a complex transition. Consumer demand is bifurcating: on one side, commodity dairy is under pressure from alternative milks and price competition; on the other side, premium dairy — verified, traceable, differentiated by breed, feed, welfare, and nutritional profile — is attracting consumers willing to pay meaningfully more for products they understand and trust.

A2 milk sits squarely in the premium differentiated segment. Its continued growth will depend on three things: maintaining the integrity of A2 claims through verified genotyping and supply chain transparency; expanding the scientific evidence base through well-designed clinical trials; and communicating benefits accurately — digestive comfort, not miracle cures.

Countries and farming systems that get this right — that build the genetic verification, the nutritional infrastructure, and the honest consumer communication — will be well-positioned in the premium dairy market of the next decade. India, with its extraordinary native breed heritage, has a structural head start. The question is whether the ecosystem can organise itself to realise that advantage at scale.

Conclusion: From Genetic Heritage to Global Market — Closing the Circle

A2 milk is not a fad. The underlying science — one amino acid substitution, differential BCM-7 release, documented digestive benefits in sensitive individuals — is real and continuing to be refined by peer-reviewed research. The Indian indigenous cattle heritage — Gir, Sahiwal, Tharparkar, and their kin — is genuinely and measurably predominantly A2A2 in genotype. The commercial market is real, growing rapidly, and driven by multiple converging consumer motivations.

But the story is larger than any single nutritional claim or market segment. A2 milk, understood correctly, is a thread that connects molecular biology to indigenous breed conservation, rural dairy economics to Ayurvedic tradition, smallholder livelihoods to global premium markets. It is a story about moving from the scarcity of under-valued native genetics to the abundance of recognised, premium, traceable dairy production — with the farmer at the centre of that value creation, not merely at the beginning of a supply chain that extracts value elsewhere.

At Shunya, we believe the right response to that story is not just to study it but to build the systems that make it real at the farm level: the nutrition infrastructure, the traceability tools, the production protocols, and the market connections that allow India’s indigenous A2 cattle to perform at their genetic potential and reward the farmers who have maintained them.

The genetic heritage is already there. The work is to make it productive, verifiable, and fairly rewarded — for the animals, the farmers, and the consumers who are increasingly choosing to understand what is in their glass.

Related Reading from Shunya:
→ Hydroponic Fodder Unit Cost Analysis — What It Takes to Build Green Nutrition Infrastructure
→ Comparative Analysis of Livestock Feed: Nutritive Value Across Feed Types
→ Women, Livestock & the Hidden Fodder Crisis: How Shunya’s FaaS is Transforming Rural India